Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.

To identify the factors regulating the proliferation of intestinal epithelium, we examined the effects of various growth factors on [3H] thymidine incorporation into the DNA of IEC-6 cells, an intestinal epithelial cell line derived from rat jejunal crypts. Insulin-like growth factor-I (IGF-I), IGF-II, and insulin stimulated the DNA and protein synthesis of IEC-6 cells in serum-free medium supplemented with transferrin, dexamethasone, and BSA (basal medium). Concentration-response experiments demonstrated that IGF-I is approximately 10 times more potent than IGF-II or insulin in producing 2- to 3-fold stimulations of DNA and protein synthesis by IEC-6 cells. In addition, IEC-6 cells proliferated slowly in the basal medium without any added growth factors. Analysis of medium conditioned by IEC-6 cells by gel filtration chromatography, RIA, HPLC, and N-terminal sequencing revealed that IEC-6 cells synthesize and secrete mature, 7,500 mo wt (M(r)) IGF-II as well as high M(r) forms of IGF-II. In addition, ligand blot, immunoblot, and N-terminal sequence analyses showed that IEC-6 cells produce the 34,000 M(r) IGF-binding protein-2 (IGFBP-2). To determine if IGFBP-2 modulates IGF responses in IEC-6 cells, the IGF-I analogs, Des-(1-3)-IGF-I and [Gln3,Ala4,Tyr15,Leu16]IGF-I, both of which have a reduced affinity for IGFBPs, were tested for their effects on IEC-6 cell proliferation. Both analogs exhibited 10-fold greater potency than IGF-I, presumably because endogenously secreted IGFBPs depress IGF-I binding to cell surface receptors. Finally, purified IGFBP-2 attenuated the DNA synthesis of IEC-6 cells in a dose-dependent manner. We conclude that IGFBP-2 secreted by intestinal epithelial cells is capable of limiting the mitogenic activity of both exogenous and endogenous IGFs by blocking the association of the growth factors with cell surface binding sites. These results further suggest that the growth of IEC-6 cells is modulated by autocrine mechanisms involving IGF-II and IGFBP-2.

[1]  D. Clemmons,et al.  Cloning and sequence determination of bovine insulin‐like growth factor binding protein‐2 (IGFBP‐2): Comparison of its structral and functional properties with IGFBP‐1 , 1992, Journal of cellular biochemistry.

[2]  M. Dehoff,et al.  Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. , 1991, Endocrinology.

[3]  N. Ling,et al.  Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. , 1991, The Journal of biological chemistry.

[4]  F. Masiarz,et al.  Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum. , 1991, The Journal of biological chemistry.

[5]  W. Lee,et al.  Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids. , 1991, Endocrinology.

[6]  L. A. Scott,et al.  Insulin and insulin-like growth factor I in early development: peptides, receptors and biological events. , 1990, Endocrine reviews.

[7]  S. Handwerger,et al.  Three distinct forms of insulin-like growth factor binding proteins are released by decidual cells in culture. , 1990, Endocrinology.

[8]  D. Clemmons,et al.  Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. , 1990, The Journal of biological chemistry.

[9]  R. Humbel,et al.  Insulin-like growth factors I and II. , 1990, European journal of biochemistry.

[10]  M. Rechler,et al.  Tissue, developmental, and metabolic regulation of messenger ribonucleic acid encoding a rat insulin-like growth factor-binding protein. , 1990, Endocrinology.

[11]  M. Rechler,et al.  The fetal rat binding protein for insulin-like growth factors is expressed in the choroid plexus and cerebrospinal fluid of adult rats. , 1989, Molecular endocrinology.

[12]  Christopher C. Binkert,et al.  Cloning, sequence analysis and expression of a cDNA encoding a novel insulin‐like growth factor binding protein (IGFBP‐2). , 1989, The EMBO journal.

[13]  M. Ranke,et al.  Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. , 1989, Endocrinology.

[14]  Christopher C. Binkert,et al.  A low molecular weight insulin-like growth factor binding protein from rat: cDNA cloning and tissue distribution of its messenger RNA. , 1989, Molecular endocrinology.

[15]  D. Clemmons,et al.  Identification of the types of insulin-like growth factor-binding proteins that are secreted by muscle cells in vitro. , 1989, The Journal of biological chemistry.

[16]  M. Bayne,et al.  Characterization of the increased biological potency in BALB/C 3T3 cells of two analogs of human insulinlike growth factor I which have reduced affinity for the 28 K cell‐derived binding protein , 1989, Journal of cellular physiology.

[17]  R. Baxter,et al.  Binding proteins for the insulin-like growth factors: structure, regulation and function. , 1989, Progress in growth factor research.

[18]  W. Wood,et al.  Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. , 1988, Molecular endocrinology.

[19]  R. Baxter,et al.  Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.

[20]  M. T. Brewer,et al.  Cloning, characterization, and expression of a human insulin-like growth factor binding protein. , 1988, Biochemical and biophysical research communications.

[21]  M. Bayne,et al.  Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor. , 1988, The Journal of biological chemistry.

[22]  R. Voutilainen,et al.  Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. , 1988, Endocrinology.

[23]  J. Wallace,et al.  The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding. , 1988, Biochemical and biophysical research communications.

[24]  J. Wallace,et al.  Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding. , 1987, Biochemical and biophysical research communications.

[25]  D. Clemmons,et al.  An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. N. Corps,et al.  Stimulation of intestinal epithelial cell proliferation in culture by growth factors in human and ruminant mammary secretions. , 1987, The Journal of endocrinology.

[27]  V. Han,et al.  Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. , 1987, Science.

[28]  D. Podolsky,et al.  Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation. , 1987, Biochemical and biophysical research communications.

[29]  W. Daughaday.  [24] Radioligand assays for insulin-like growth factor II , 1987 .

[30]  D. Teplow,et al.  Identification of a peptide fragment from the carboxyl-terminal extension region (E-domain) of rat proinsulin-like growth factor-II. , 1985, Journal of Biological Chemistry.

[31]  P. Zumstein,et al.  Amino acid sequence of a variant pro-form of insulin-like growth factor II. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Johnson.  Regulation of gastrointestinal growth , 1984 .

[33]  A. Ullrich,et al.  Insulin-like growth factor II precursor gene organization in relation to insulin gene family , 1984, Nature.

[34]  G. Smith,et al.  Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. D'ercole,et al.  Evidence that somatomedin is synthesized by multiple tissues in the fetus. , 1980, Developmental biology.

[36]  A. Quaroni,et al.  Chapter 20 Establishment and Characterization of Intestinal Epithelial Cell Cultures , 1980 .

[37]  A. Moses,et al.  Purification and characterization of multiplication-stimulating activity. Insulin-like growth factors purified from rat-liver-cell-conditioned medium. , 1980, European journal of biochemistry.

[38]  E. Rinderknecht,et al.  Primary structure of human insulin‐like growth factor II , 1978, FEBS letters.

[39]  R. Furlanetto,et al.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. , 1977, The Journal of clinical investigation.

[40]  A. Dahlqvist,et al.  METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES. , 1964, Analytical biochemistry.